JP Morgan Maintains Neutral on Cardlytics, Lowers Price Target to $35

JP Morgan analyst Doug Anmuth maintains Cardlytics (NASDAQ:CDLX) with a Neutral and lowers the price target from $47 to $35.

JP Morgan analyst Doug Anmuth maintains Cardlytics (NASDAQ:CDLX) with a Neutral and lowers the price target from $47 to $35.

Total
0
Shares
Related Posts